F.D.A. advisers voted that the benefits of a nonprescription pill outweigh the risks. If the agency decides to move on the recommendation, the progestin-only contraceptive could be in stores within a few months.
Tag: Food and Drug Administration
-
F.D.A. Advisers Say Benefits of Over-the-Counter Birth Control Pill Outweigh Risks
The agency is expected to decide this summer whether to allow the first nonprescription sales of an oral contraceptive in the United States.
-
F.D.A. Advisers Weigh Allowing First U.S. Over-the-Counter Birth Control Pill
The panel heard strong support from the company and many doctors but concern from F.D.A. scientists.
-
What if You Could Save Someone From an Overdose?
A nasal spray could change the course of the opioid epidemic.
-
Sacklers Gave Millions to Institution That Advises on Opioid Policy
Even as the nation’s drug crisis mounted, the National Academies of Sciences, Engineering and Medicine continued to accept funds from some members of the Sackler family, including those involved with Purdue Pharma.